Fracture in the Elderly Multidisciplinary Rehabilitation (FEMuR): a phase II randomised feasibility study of a multidisciplinary rehabilitation package following hip fracture by Williams, Nefyn H et al.
  
 
 
 
warwick.ac.uk/lib-publications 
 
 
 
 
 
Original citation: 
Williams, Nefyn H, Roberts, Jessica L., Din, Nafees Ud, Totton, Nicola, Charles, Joanna M, 
Hawkes, C. M., Morrison, Val, Hoare, Zoë, Williams, Michelle, Pritchard, Aaron W, Alexander, 
Swapna, Lemmey, Andrew, Woods, Robert T, Sackley, Catherine, Logan, Pip, Edwards, 
Rhiannon T and Wilkinson, Clare. (2016) Fracture in the Elderly Multidisciplinary 
Rehabilitation (FEMuR): a phase II randomised feasibility study of a multidisciplinary 
rehabilitation package following hip fracture. BMJ Open, 6 (10). e012422. 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/85270 
 
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work of researchers of the 
University of Warwick available open access under the following conditions. 
 
This article is made available under the Creative Commons Attribution 4.0 International 
license (CC BY 4.0) and may be reused according to the conditions of the license.  For more 
details see: http://creativecommons.org/licenses/by/4.0/   
 
A note on versions: 
The version presented in WRAP is the published version, or, version of record, and may be 
cited as it appears here. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk 
 
Fracture in the Elderly Multidisciplinary
Rehabilitation (FEMuR): a phase II
randomised feasibility study of a
multidisciplinary rehabilitation package
following hip fracture
Nefyn H Williams,1,2 Jessica L Roberts,1 Nafees Ud Din,1 Nicola Totton,1
Joanna M Charles,1 Claire A Hawkes,3 Val Morrison,4 Zoe Hoare,1
Michelle Williams,1 Aaron W Pritchard,1 Swapna Alexander,2 Andrew Lemmey,5
Robert T Woods,1 Catherine Sackley,6 Pip Logan,7 Rhiannon T Edwards,1
Clare Wilkinson1
To cite: Williams NH,
Roberts JL, Din NU, et al.
Fracture in the Elderly
Multidisciplinary
Rehabilitation (FEMuR): a
phase II randomised
feasibility study of a
multidisciplinary rehabilitation
package following hip
fracture. BMJ Open 2016;6:
e012422. doi:10.1136/
bmjopen-2016-012422
▸ Prepublication history and
additional material is
available. To view please visit
the journal (http://dx.doi.org/
10.1136/bmjopen-2016-
012422).
Received 26 April 2016
Revised 18 July 2016
Accepted 25 August 2016
For numbered affiliations see
end of article.
Correspondence to
Dr Nefyn H Williams;
nefyn.williams@bangor.ac.uk
ABSTRACT
Objective: To conduct a rigorous feasibility study for
a future definitive parallel-group randomised controlled
trial (RCT) and economic evaluation of an enhanced
rehabilitation package for hip fracture.
Setting: Recruitment from 3 acute hospitals in North
Wales. Intervention delivery in the community.
Participants: Older adults (aged ≥65) who received
surgical treatment for hip fracture, lived independently
prior to fracture, had mental capacity (assessed by
clinical team) and received rehabilitation in the North
Wales area.
Intervention: Remote randomisation to usual care
(control) or usual care+enhanced rehabilitation package
(intervention), including six additional home-based
physiotherapy sessions delivered by a physiotherapist
or technical instructor, novel information workbook
and goal-setting diary.
Primary and secondary outcome measures:
Primary: Barthel Activities of Daily Living (BADL).
Secondary measures included Nottingham Extended
Activities of Daily Living scale (NEADL), EQ-5D,
ICECAP capability, a suite of self-efficacy, psychosocial
and service-use measures and costs. Outcome
measures were assessed at baseline and 3-month
follow-up by blinded researchers.
Results: 62 participants were recruited, 61 randomised
(control 32; intervention 29) and 49 (79%) completed
3-month follow-up. Minimal differences occurred
between the 2 groups for most outcomes, including
BADL (adjusted mean difference 0.5). The intervention
group showed a medium-sized improvement in the
NEADL relative to the control group, with an adjusted
mean difference between groups of 3.0 (Cohen’s d 0.63),
and a trend for greater improvement in self-efficacy and
mental health, but with small effect sizes. The mean cost
of delivering the intervention was £231 per patient. There
was a small relative improvement in quality-adjusted life
year in the intervention group. No serious adverse events
relating to the intervention were reported.
Conclusions: The trial methods were feasible in terms
of eligibility, recruitment and retention. The effectiveness
and cost-effectiveness of the rehabilitation package
should be tested in a phase III RCT.
Trial registration number: ISRCTN22464643; Results.
BACKGROUND
Proximal femoral fracture, more commonly
referred to as hip fracture, is a common,
major health problem in old age1 and as the
population ages, the number of elderly
people falling and fracturing their hips is
projected to increase further.2 3 Such frac-
tures are strongly associated with decreased
bone mineral density, increased age, prior
fragility fracture, cognitive impairment, other
health problems, undernutrition, frailty, poor
Strengths and limitations of this study
▪ This study was designed to assess the feasibility
of trial methods and intervention delivery and
was therefore not powered to test the effective-
ness or cost-effectiveness of the intervention.
▪ Different outcome measures were assessed to
determine which would be the most suitable for
a larger definitive randomised controlled trial.
▪ Comparative data were collected from an anon-
ymised cohort, allowing comparison of
characteristics with recruited participants and
identification of differences.
▪ Ethical approval was granted only for recruitment
of patients with mental capacity to consent,
therefore excluding a large number of potential
participants lacking capacity.
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physical functioning, vision problems and weight loss.4
Mortality is high with 14–58% dying within the following
12 months.5 6 A review of the long-term disability asso-
ciated with proximal femoral fracture found that 29%
did not regain their level of functioning after 1 year in
terms of restrictions of activities of daily living.7 Many
who were living independently before their fracture lose
their independence afterwards, which imposes a large
cost burden on society amounting to about £2.3 billion
a year in the UK.8
The National Institute for Health and Care Excellence
(NICE) has issued guidelines for the management of
hip fracture.9 As well as prompt surgical treatment and
the management of associated medical needs, the guide-
lines recommend a programme of multidisciplinary
rehabilitation. Such rehabilitation starts while in hospital
during postoperative recovery, continues in the commu-
nity following hospital discharge and has the potential
to maximise recovery, enhance quality of life and main-
tain independence. While individual components of
such programmes show promise, there is insufﬁcient evi-
dence of overall effectiveness or cost-effectiveness of an
overall care pathway.10–12
The ﬁrst phase of this research project developed a
new community-based rehabilitation intervention13
within the Medical Research Council’s (MRC) frame-
work for complex intervention development.14 The aim
of the second phase of the present study was to assess
the feasibility of conducting a deﬁnitive randomised
controlled trial (RCT) of this intervention and its
acceptability through focus groups with therapists,
patients and carers; and to conduct a concurrent eco-
nomic evaluation.
STUDY OBJECTIVES
1. To assess the feasibility of a future deﬁnitive RCT by
assessing eligibility, recruitment and retention rates,
exploring the willingness of patient participants to be
randomised and the willingness of patients and
carers to complete process and outcome measures.
2. To assess the acceptability of the rehabilitation pro-
gramme among patients, carers and clinicians, and to
identify any adverse events.
3. To produce means and SDs of the quantitative mea-
sures, so that effect sizes can be calculated for plan-
ning the future RCT.
4. To explore the methodological issues for conducting
an economic evaluation alongside a future RCT, and
report exploratory economic analyses.
STUDY DESIGN
Phase II comprised the second stage of the MRC frame-
work14 and consisted of a randomised feasibility study,
including focus groups of the multidisciplinary rehabili-
tation teams, hip fracture patients and their carers. An
anonymous cohort study of all proximal femoral fracture
patients was also conducted to assess the feasibility of
recruiting a representative sample by comparing the
recruited participants with the cohort population.
METHOD
The protocol for this phase II study has been described
elsewhere.13 The cohort consisted of an anonymised
data set of all patients aged 65 years and over admitted
to the three main acute hospitals of Betsi Cadwaladr
University Health Board (BCUHB) in North Wales
(Wrexham Maelor, Ysbyty Glan Clwyd and Ysbyty
Gwynedd) with hip fracture during the ﬁrst 6 months
of the study period. They were followed up for
3 months. The following data were collected: the
number admitted with proximal femoral fracture; the
number who fulﬁlled the inclusion criteria for the ran-
domised feasibility study; the number of deaths, serious
complications and readmissions. Participants to the
feasibility study were recruited on the orthopaedic
wards while recovering from surgical treatment for
proximal femoral fracture. We also recruited carers
who were relatives or friends who provided help with
activities of daily living for most days of the week. The
speciﬁc inclusion criteria for hip fracture patients were
given below.
Inclusion criteria
▸ Age 65 years or older
▸ Recent proximal hip fracture
▸ Surgical repair by replacement arthroplasty or
internal ﬁxation
▸ Living in their own home prior to hip fracture
▸ Capacity to give informed consent, as assessed by the
clinical team in the acute hospital. Patients with post-
operative delirium were approached if this was
resolved prior to discharge from the acute hospital.
▸ Living and receiving rehabilitation from the NHS in
the area covered by BCUHB
Exclusion criteria
▸ Living in residential or nursing homes prior to hip
fracture
▸ Not able to understand Welsh or English
Randomisation
Randomisation was performed remotely by researchers
conducting baseline assessments, generating an email to
physiotherapists delivering the intervention who assigned
participants to the appropriate groups. Randomisation
was by dynamic allocation15 to protect against subversion
while ensuring that the trial maintained good balance
to the allocation ratio of 1:1 within each stratiﬁcation vari-
able and across the trial. Participants were stratiﬁed by:
(1) hospital and (2) gender. Stratiﬁcation by hospital was
necessary as each hospital has differing usual care path-
ways and, due to the geography of the area, different
therapy teams delivered the intervention in different
areas.
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Study interventions
An ‘enhanced’ rehabilitation intervention to improve
patients’ self-efﬁcacy and increase the amount and
quality of patients’ practice of physical exercise and activ-
ities of daily living was compared with usual rehabilita-
tion care. This intervention consisted of a patient-held
information workbook and goal-setting diary (see online
supplementary ﬁles 1 and 2) provided to the patient
before or soon after discharge from the acute hospital.
Six additional therapy sessions were delivered post-
discharge by physiotherapists and technical instructors
in the patient’s place of residence or outpatients’ depart-
ment if required, with the timescale of delivery being
decided by the therapist according to patient’s individ-
ual needs. Session content was tailored to the individual
and led by goals set by the patient in their initial inter-
vention session, using the information workbook and
supported by the therapist’s clinical expertise of what
was realistic and achievable for the patient. Patients and
therapists reviewed and amended goals throughout the
3-month intervention period. The theory underpinning
how the individual components interact to achieve desir-
able outcomes is discussed in detail elsewhere.13 Usual
care was variable, consisting of multidisciplinary rehabili-
tation delivered by the acute hospital, community hos-
pital and community services depending on patients’
individual needs at different times during their recovery
and on the availability and accessibility of services in dif-
ferent areas. Care pathways in this area did not include
the provision of rehabilitation information leaﬂets on
discharge from the acute hospital and any goal-setting
activities were therapist-led.
Outcome measures
Outcomes were collected in a variety of ways.
Demographic data were collected from patients and
their records. Researchers collected recruitment rates
from their screening and recruitment records. Outcome
measures (box 1) were completed by participants,
assisted by a member of the research team who was
blinded to treatment allocation, at baseline and at
3-month follow-up. Baseline measures were completed
as soon as possible after surgery on the acute ortho-
paedic ward, inpatient rehabilitation ward or in the
patient’s home following discharge. Follow-up measures
were completed at the patient’s place of residence or in
the physiotherapy department when attending for phys-
ical function tests, depending on the preference of the
participant. Physical function was objectively assessed by
the researcher at baseline using the grip strength test.16
At 3-month follow-up, a physiotherapist measured other
objective tests of physical function in addition to the
grip strength test, such as 30 s sit-to-stand,17 8-foot
get-up-and-go18 and the 50-foot walk test.19 These were
performed in the physiotherapy gym, or in the patient’s
home if they were unable to travel. In addition, carers
completed the Caregiver Strain Index.20
Trial analysis
Feasibility was assessed by measuring eligibility, recruit-
ment and retention rates.
To calculate a representative effect size for each of the
outcome measures, either analysis of covariance, adjust-
ing each patient’s follow-up score with their baseline
score, or a student’s t-test, when no baseline data were
available, was completed as outlined in the protocol.13
These methods established the 3-month follow-up
outcome measurements of the two treatment groups. All
analysis was completed on an intention-to-treat basis.
In order to estimate the SD of the primary outcome
measure to be used in a power calculation for a future
deﬁnitive RCT, we aimed for a sample size of 50 partici-
pants completing the study.35
An exploratory economic evaluation was conducted
from a public sector multiagency perspective.13
Intervention costs for the enhanced rehabilitation pro-
gramme were obtained from the local health board and
applied to information received from the healthcare pro-
fessionals delivering the intervention (eg, salary band,
time spent with patient, costs of travel). Participant
service use was obtained using the CSRI questionnaire,34
and was fully costed to obtain a mean cost per participant,
per arm of health and social care service use, using
national unit costs.32 36 The EQ-5D (3L) was used to cal-
culate quality-adjusted life years (QALYs) over the
3-month study period, using the area under the curve
method;32 and ICECAP-O was used to calculate a capabil-
ity index score for a cost consequences analysis.
Focus groups
Detailed methods of sampling and analysis for focus
groups are reported elsewhere.13 In brief, patients were
asked at recruitment to the feasibility study if they were
willing to take part in future focus groups. All those who
expressed an interest were invited to take part at a later
stage of their rehabilitation. Focus groups were arranged
in areas local to the respondents. Clinical staff involved in
the study were invited to take part in focus groups at the
acute hospital they were associated with. Where clinical
Box 1 Patient-reported outcome measures
Primary outcome measure
Barthel Index (BADL)21
Secondary outcome measures
Abbreviated Mental Test Score (AMTS)22
Nottingham Extended Activities of Daily Living (NEADL) scale23
Hospital Anxiety and Depression Scale (HADS)24
Visual Analogue Scale (VAS) for hip pain intensity25
General Self-Efficacy Scale (GSES)26
Falls Efficacy Scale-International (FES-I)27 28
Self-efficacy for exercise scale29
Visual Analogue Scale-Fear of Falling (VAS-FoF)30
EuroQol EQ-5D (3L)31
ICEpop CAPability measure for Older people (ICECAP-O)32 33
Client Service Receipt Inventory (CSRI).34
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commitments prevented attendance, a one-to-one phone
interview was offered as an alternative. Focus groups and
interviews were led by a topic guide (see online
supplementary ﬁles 3 and 4) recorded, transcribed and
analysed using the framework approach to thematic ana-
lysis.37 Analysis was conducted by a study researcher, an
independent researcher experienced in qualitative analysis,
and overseen by the chief investigator to ensure credibility.
RESULTS
Cohort
Four hundred proximal hip fracture patients were identi-
ﬁed in the anonymised cohort study between June and
November 2014. Comparison of the cohort population
with participants in the randomised feasibility study
demonstrated that proportions were similar with regard
to gender, type of hip fracture and type of hip surgery
(table 1). However, the cohort population was slightly
older with a mean age difference of 4.5 years. The pro-
portion admitted to each of the three acute hospitals
was similar, but more than half of the feasibility study
participants were recruited from Ysbyty Glan Clwyd. In
the cohort, 58 patients (15%) had been readmitted to
hospital at 3-month follow-up and there were 69 deaths
(17%) (see online supplementary ﬁle 5, table 1).
Eighty-nine (22%) patients in the cohort lacked mental
capacity and the mean duration of acute hospital admis-
sion was 18.8 days (SD 19.4).
Feasibility study
Baseline
Between June 2014 and March 2015, 593 patients with
proximal femoral fracture were screened for eligibility,
Table 1 Characteristics of patients in cohort and trial data sets
Characteristic
Trial data
Mean (SD); range
Cohort data
Mean (SD); range
Age 79.4 (7.6); 66–99 83.9 (7.7); 66–101
Trial data
N (%)
Cohort data
N (%)
Gender
Male 15 (25) 108 (27)
Female 46 (75) 292 (73)
Type of fracture
Intracapsular 27 (44) 195 (49)
Extracapsular 20 (33) 126 (31)
Missing 14 (23) 79 (20)
Extracapsular fracture
Pertrochanteric 1 (5) 2 (2)
Intertrochanteric 11 (55) 130 (82)
Subtrochanteric 2 (10) 13 (10)
Missing 6 (30) 8 (6)
Type of surgery
Total hip arthroplasty 5 (8) 27 (6)
Hemiarthroplasty 29 (47) 159 (40)
Internal fixation 17 (28) 151 (38)
Intramedullary nailing 2 (3) 16 (4)
No surgery 0 (0) 29 (7)
Missing 8 (14) 18 (5)
Hospital
Ysbyty Gwynedd 11 (18) 146 (37)
Ysbyty Glan Clwyd 34 (56) 123 (31)
Wrexham Maelor 16 (26) 131 (33)
Readmissions 2 (3) 58 (15)
Deaths 1 (2) 69 (17)
Accommodation Before admission After discharge Before admission After discharge
Private property 59 (97%) 44 (72%) 313 (78%) 104 (26%)
Sheltered accommodation 2 (3%) 3 (5%) 11 (3%) 1 (<1%)
Residential home 0 (0%) 1 (2%) 34 (8%) 12 (3%)
Nursing home 0 (0%) 0 (0%) 36 (9%) 29 (7%)
Community hospital 0 (0%) 1 (2%) 3 (1%) 224 (56%)
Other acute hospital 0 (0%) 0 (0%) 1 (<1%) 6 (1%)
Missing 0 (0%) 12 (19%) 2 (<1%) 24 (6%)
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of which 266 (45%) were eligible (ﬁgure 1). The main
reason for ineligibility was lack of mental capacity
(49%). Out of those eligible, 193 (73%) were invited to
participate and 62 (23% of the eligible population)
agreed to participate. The main reason for non-
participation was the perceived burden of the study. The
majority of patients had two visits from researchers
before they were recruited, and many requested a
second visit to discuss the study after they had been dis-
charged. From the recruited participants, 41 carers were
identiﬁed, with 31 agreeing to participate (76%). The
mean age of the intervention group was 2.9 years older
than the control group, but the age of study participants
ranged from 66 to 99 years (table 2). The proportions in
the two groups were similar according to gender, living
status, type of property, type of fracture, type of surgery
and admitting hospital. After the hospital admission,
there was a small discrepancy between those discharged
directly to their place of usual residence (34% in the
intervention group; 53% in the control group) and
those sent to a community hospital for rehabilitation
(52% in the intervention group; 22% in the control
group). The baseline scores of the outcome measures
and physical function tests were similar between the two
groups (table 3). However, the Nottingham Extended
Activities of Daily Living score was 2.4 points higher in
the control group.
Three-month follow-up
There were nine withdrawals, one before baseline and
eight during the intervention (four from each group)
(see online supplementary ﬁle 5, table 2). Four patients
could not be contacted at follow-up, which gives a
patient retention rate of 79%. Six of the carers withdrew
during the study and seven were lost to follow-up.
Eighteen completed the follow-up questionnaire, giving
a carer retention rate of 44%. Nine adverse events were
reported (three in intervention, six in control). Six of
these were deemed as serious, including two readmis-
sions (3%), one in the control and one in the
Figure 1 Feasibility study participant flow diagram.
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intervention group, and one death (2%) in the control
group, but none were related to the study (see online
supplementary ﬁle 5, table 1). The differences between
the two groups at 3-month follow-up are shown in
tables 3 and 4. Cohen’s d effect sizes have been calcu-
lated for each of the outcome measures. The main
outcome measure the BADL, and most secondary out-
comes had small effect sizes in favour of the intervention
group. However, the NEADL showed a medium effect
size, with a Cohen’s d of 0.63, but a wide 95% CI (−0.01
to 1.26), also in favour of the intervention group. One
of the physical function tests, the 50-foot walk test, was
completed in a shorter time in the control group with a
medium effect size (Cohen’s d of 0.40), but again a wide
95% CI (−0.41 to 1.20). This seemed to be related to
one outlier and so a sensitivity analysis was completed
with this participant removed. This changed the effect
size to 0.02 (95% CI of −0.80 to 0.84). General self-
efﬁcacy and self-efﬁcacy for exercise had the lowest rate
of completion at follow-up; with patients expressing con-
fusion to researchers conducting the interviews about
how to complete these measures (see online
supplementary ﬁle 5, table 3).
Economic analysis
At 3-month follow-up, 49 sets of data were available for
analysis. We excluded 6 because of missing data, leaving
43 complete cases for the economic (cost-consequence)
analysis (intervention n=21, control n=22). The eco-
nomic sample represented 72% of the main clinical
sample, with similar baseline characteristics (eg, gender,
mean age, living status, type of property, type of fracture
and type of surgery). The control group had lower base-
line scores for the EQ-5D36 index and VAS, and ICECAP
O32 capability index than the intervention group.
However, both groups had improved scores at follow-up
(table 5). The difference in QALYs between the two
groups was 0.02 (1000 bootstrapped 95% CI −0.02 to
Table 2 Characteristics of patients split by treatment group
Characteristic
Overall
mean (SD); range
Control
mean (SD); range
Intervention
mean (SD); range
Age 79.4 (7.6);
66–99
78.0 (8.3);
66–99
80.9 (6.6);
69–94
Abbreviated Mental Test Score (AMTS) 9.1 (1.3);
5–10
9.0 (1.2);
6–10
9.1 (1.3);
5–10
Overall
N (%)
Control
N (%)
Intervention
N (%)
Gender
Male 15 (25) 9 (28) 6 (21)
Female 46 (75) 23 (72) 23 (79)
Usually lives
Lives alone 31 (51) 16 (50) 15 (52)
Lives with others 30 (49) 16 (50) 14 (48)
Accommodation
Owner-occupied property 48 (79) 24 (75) 24 (83)
Privately rented property 5 (8) 2 (6) 3 (10)
Housing association/local authority property 6 (10) 4 (13) 2 (7)
Sheltered accommodation 2 (3) 2 (6) 0 (0)
Type of fracture
Intracapsular 27 (44) 16 (50) 11 (38)
Extracapsular 20 (33) 9 (28) 11 (38)
Not recorded/available 14 (23) 7 (22) 7 (24)
Type of surgery
Total hip arthroplasty 5 (8) 4 (13) 1 (3)
Hemiarthroplasty 29 (47) 15 (47) 14 (48)
Internal fixation 17 (28) 7 (22) 10 (35)
Intramedullary nailing 2 (3) 2 (6) 0 (0)
Not recorded/available 8 (14) 4 (12) 4 (14)
Discharged directly to usual residence
Yes 27 (44) 17 (53) 10 (34)
No 22 (36) 7 (22) 15 (52)
Missing 12 (20) 8 (25) 4 (14)
Hospital
Ysbyty Gwynedd 11 (18) 6 (19) 5 (17)
Ysbyty Glan Clwyd 34 (56) 17 (53) 17 (59)
Wrexham Maelor 16 (26) 9 (28) 7 (24)
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Table 3 Outcome measures including raw scores and adjusted mean differences from analysis of covariance analysis
Baseline Follow-up
Outcome measure
Control
group
Mean
(SD)
Intervention
group
Mean (SD)
Control
group
Mean
(SD)
Intervention
group
Mean (SD)
Scale
range
Adjusted mean
difference
between
groups at
follow-up (95%
CI)
Effect size (95%
CI)
Primary outcome measure
Barthel index 17.8 (3.4)
n=32
17.8 (2.4)
n=27
17.7 (3.0)
n=22
18.2 (2.9)
n=21
0–20 0.5 (−0.5 to 1.6) 0.29 (−0.31 to 0.89)
Secondary outcome measures
General Self-Efficacy Scale (GSES) 31.6 (5.6)
n=31
33.6 (5.1)
n=27
30.5 (7.8)
n=19
33.7 (7.0)
n=22
10–40 1.3 (−2.5 to 5.0) 0.20 (−0.42 to 0.81)
Hospital Anxiety and Depression Scale (HADS) 12.8 (9.0)
n=31
11.0 (4.8)
n=24
11.0 (8.2)
n=22
8.7 (6.0)
n=20
0–42 −1.2 (−4.8 to
2.6)
0.20 (−0.41 to 0.81)
Nottingham Extended Activities of Daily Living (NEADL) 16.1 (5.5)
n=29
13.7 (7.4)
n=27
14.2 (5.7)
n=20
15.8 (6.0)
n=20
0–22 3.0 (−0.4 to 6.4) 0.63 (−0.01 to 1.26)
Visual Analogue Scale (VAS) for hip pain intensity 4.2 (2.4)
n=32
4.1 (2.3)
n=28
3.4 (3.1)
n=23
2.9 (2.9)
n=25
0–10 −0.2 (−1.7 to
1.3)
0.00 (−0.58 to 0.58)
Carer outcome measure
Carer strain index (CSI) 2.6 (3.1)
n=12
3.5 (3.4)
n=16
3.3 (3.7)
n=8
2.7 (2.1)
n=7
0–13 −1 (−5.1 to 3.0) 0.35 (−0.68 to 1.37)
Physical function tests
Grip strength 21.0
(10.1)
n=30
20.0 (7.2)
n=26
23.4
(12.3)
n=17
19.5 (8.3)
n=12
Unlimited 1.2 (−1.7 to 4.2) 0.35 (−0.40 to 1.09)
Bold typeface denotes medium effect size.
W
illiam
s
NH,etal.BM
J
Open
2016;6:e012422.doi:10.1136/bm
jopen-2016-012422
7
O
p
e
n
A
c
c
e
s
s
0.06), equating to 8 days gained in the intervention
group. The difference in capability indices between the
two groups was zero (1000 bootstrapped 95% CI −0.11
to 0.22) (table 5). It cost a total of £6711 (£231 per
person) to deliver the intervention. At baseline, partici-
pants in the control group accessed more services than
the intervention group. GPs were the health professional
the participants were most likely to see, with practice
nurses their second highest accessed healthcare profes-
sional. During the 3 months prior to baseline costs to
primary care services were minimal, with the costs of sec-
ondary (hospital) services accounting for the majority of
total service costs (98%). During the 3-month prior to
follow-up, the control and intervention groups accessed
primary care services and social care services, predomin-
antly. There were high levels of polypharmacy in the eco-
nomic sample, on average, taking more than ﬁve
medicines at the time of completing the CSRI question-
naire.34 Service use costs were mainly accrued by second-
ary (hospital) services (96%), as patients underwent
surgery and required time in hospital to recover.
Fifty-one per cent (n=22) of the sample reported longer
than average inpatient stays postsurgery. At follow-up,
the intervention group reported an average length of
stay of 15.2 days, and the control group 10.5 days in an
inpatient orthopaedic trauma ward, compared with the
NHS average length of stay of 14.3 days. Also at
follow-up, the intervention group reported an average
Table 5 Economic outcome measures and costs*
Intervention group (n=21) Control group (n=22)
Outcome measures and costs
Baseline
Mean (SD)
3 month
follow-up
Mean (SD)
Baseline
Mean (SD)
3 month
follow-up
Mean (SD)
Difference between
groups (1000
bootstrapped 95% CI)
EQ-5D (3L) utility index score 0.50 (0.26) 0.37 (0.43) 0.66 (0.27) 0.60 (0.27) –
EQ-5D (3L) VAS 64.43
(16.37)
55.14 (25.72) 71.10
(17.89)
68.55 (18.44)
ICECAP O capability index 0.82 (0.11) 0.75 (0.21) 0.84 (0.13) 0.78 (0.19)
Mean QALY over 3 months (1000
bootstrapped 95% CI)
0.15 (0.12 to 0.17) 0.12 (0.09 to 0.15) 0.02 (−0.02 to 0.06)
Mean change in ICECAP O capability
index over 3 months (1000
bootstrapped 95% CI)
−0.03 (−0.08 to −0.03) −0.03 (−0.12 to 0.07) 0 (−0.11 to 0.22)
Mean total service use costs at
follow-up including cost of intervention
(1000 bootstrapped 95% CI)
£149 243 (£119 376 to
£186 036)
£105 244 (£78 935 to
£132 971)
£43 999 (£4027 to
£88 818)
*Mean EQ-5D utility indices, EQ-5D VAS scores, ICECAP O indices, QALYs and change in ICECAP O capability indices rounded to two
decimal places; total service use costs rounded to the nearest £.
EQ-5D (3L), EuroQol-5 Dimensions (3 Levels); ICECAP O, ICEpop CAPability measure for Older people; QALY, quality-adjusted life year.
Table 4 Outcome measures including raw scores and effect size
Follow-up
Outcome measure
Control
group
Mean (SD)
Intervention
group
Mean (SD)
Mean difference
between groups at
follow-up (95% CI)
Scale
range Effect size (95% CI)
Secondary outcome measures
Falls Efficacy Scale-International
(FES-I)
36.2 (14.9)
n=17
32.0 (12.2)
n=20
−4.2 (−13.2 to 4.8) 16–64 −0.31 (−0.96 to 0.35)
Self-Efficacy for Exercise Scale (SEE) 49.9 (21.7)
n=18
58.2 (17.8)
n=18
8.3 (−5.2 to 21.7) 0–80 0.42 (−0.25 to 1.08)
Visual Analogue Score-fear of falling
(VAS-FOF)
4.8 (2.9)
n=24
5.0 (2.5)
n=23
0.2 (−1.4 to 1.8) 0–10 0.07 (−0.50 to 0.64)
Physical function tests
Eight-Foot Get-Up-and-Go Test 13.6 (6.1)
n=15
12.9 (6.0)
n=12
0.6 (−5.4 to 4.2) Unlimited 0.12 (−0.64 to 0.88)
Fifty-Foot Walk Test 19.3 (6.7)
n=12
31.5 (42.3)
n=12
12.2 (−13.5 to 37.8) Unlimited 0.40 (−0.41 to 1.20)
Thirty-second Sit To Stand 11.0 (3.6)
n=11
10.1 (3.9)
n=10
−0.9 (−4.3 to 2.5) Unlimited 0.24 (−0.62 to 1.10)
Bold typeface denotes medium effect size.
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length of stay at a rehabilitation inpatient ward of
12.1 days, and the control group 18.8 days, compared
with the NHS average of 11.6 days. Longer inpatient
stays were reported by 67% (n=14) of the intervention
group and 36% (n=8) of the control group. The mean
total service use costs at follow-up (including interven-
tion costs) in the intervention group were £43 999 (1000
bootstrapped 95% CI £4027 to £88 818) higher than the
control group (table 5). This was due to a larger propor-
tion of the intervention group having prolonged
inpatient stays compared with the control group.
Focus groups
Four focus groups were conducted with 13 patients and
6 carers and 2 focus groups with 7 healthcare profes-
sionals involved in the intervention (table 6). Because of
the geographical spread of participants and clinical com-
mitments of therapists in Gwynedd and Anglesey, it was
not possible to conduct focus groups in this area, but a
control group participant was able to attend a focus
group in central region and one physiotherapist and two
technical instructors participated in individual tele-
phone interviews. The study was acceptable to patients,
carers and therapists and the intervention was viewed
positively. The most useful component according to par-
ticipants was the extra sessions that they received. The
goal-setting diary and workbook were seen as useful sup-
porting documents by the majority of intervention
group participants. Other ﬁndings were that in the
context of variable usual rehabilitation care, which led
to uncertainty among patients and carers about what to
expect, the role of the therapist was extremely important
in managing patients’ expectations. Lack of information,
particularly in the usual care group, led to unrealistic
expectations in patients, with anger and frustration at
their perceived lack of progress, which was addressed to
some degree by the study intervention documents. An
important part of the therapist’s role was to reassure
patients that they were progressing normally, and to give
patients conﬁdence that they could perform their
Table 6 Focus group participant details
Participant type Location Attendees
Patient and carers in the control
group
East Patient, F, 69 years, 14 months postdischarge, discharged directly home and
Carer, M
Patient, F, 80 years, 14 months postfracture, discharged directly home and
Carer, M
Patient, M, 67 years, 7 months postdischarge, discharged directly home
(n=5)
Patient and carers in the control
group
Central Patient, F, 67 years, 11 months postfracture, discharged directly home
Patient, M, 67 years, 12 months postfracture, discharged directly home and
Carer, F
Patient, F, 83 years, 6 months postfracture, inpatient rehabilitation prior to
discharge home
Patient, F, 75 years, 12 months postfracture, inpatient rehabilitation prior to
discharge home
(n=5)
Patient and carers in the
intervention group
East Patient, F, 86 years, 5 months postfracture, discharged directly home
Patient, F, 86 years, 8 months postfracture, inpatient rehabilitation prior to
discharge home
Patient, F, 69 years, 14 months postfracture, discharged directly home
(n=3)
Patient and carers in the
intervention group
Central Patient, F, 70 years, 7 months postfracture, discharged directly home
Patient, M, 81 years, 6 months postfracture, discharged directly home and
Carer, F
Patient, M, 74 years, 5 months postfracture, discharged directly home and
Carer, F
Patient, F, 80 years, 7 months postfracture, inpatient rehabilitation prior to
discharge home and Carer, M
(n=7)
Healthcare professionals East Clinical specialist physiotherapist, two orthopaedic physiotherapists,
physiotherapy technical instructor
(n=4)
Healthcare professionals Central Orthopaedic acute physiotherapist, rotational physiotherapist, physiotherapy
technical instructor
(n=3)
Healthcare professionals West One-to-one phone interviews were conducted with an acute orthopaedic
physiotherapist and two technical instructors
Williams NH, et al. BMJ Open 2016;6:e012422. doi:10.1136/bmjopen-2016-012422 9
Open Access
physical activities safely and to counteract the fear of
falling. This was particularly important to patients at the
beginning of their rehabilitation, but therapists, particu-
larly fully qualiﬁed physiotherapists, often overlooked its
importance. Technical instructors appeared to be more
aware of their role in psychological support of the
patient, in addition to physical rehabilitation. Patients
valued individualised care and support, which included
the recognition of patients’ unique rehabilitation needs,
tailoring of care to suit these needs, and personalised
goal-setting as a motivational tool. These activities were
well supported by the workbook and the goal-setting
diary and therapists commented that these supporting
documents may be of particular use to those with cogni-
tive impairment. Regular home visits with intervention
therapists provided consistency and allowed a relation-
ship to build between patient and rehabilitation therap-
ist, which was important for patient engagement.
DISCUSSION
Summary of main findings
Participants recruited to the cohort and feasibility study
were similar in terms of gender, type of hip fracture and
type of surgery, but the feasibility study participants were
younger and less likely to die or be readmitted to hos-
pital during the 3-month follow-up period. A mean
AMTS score of 9.1 also indicates low levels of cognitive
impairment. Recruitment and retention rates were
acceptable, although the recruitment process was chal-
lenging due to the need to approach patients soon after
surgery following a traumatic injury. The majority of
patients required multiple visits prior to consent. The
trial methods were feasible in terms of randomisation
and outcome measure collection. The new rehabilitation
intervention was acceptable to patients and clinicians.
The intervention group showed a moderate improve-
ment in their ability to perform activities of daily living
as well as small improvements in self-efﬁcacy and mental
health. Paradoxically, the control group showed a mod-
erate improvement in the 50-foot walk test, but this was
shown to be down to an outlier. The NEADL was more
responsive than the BADL and the most responsive
measure of self-efﬁcacy was the FES-I.
The economic evaluation found that the intervention
cost £231 per person to deliver. There was a small relative
improvement in QALY in the intervention group, albeit
with a wide CI. There was an equal drop in ICECAP-O
capability indices in both groups. Service use costs were
greater in the intervention group, due to longer inpatient
stays unrelated to the rehabilitation intervention.
The focus group ﬁndings were that in the context of
variable usual rehabilitation care, the role of the therap-
ist was extremely important in managing patients’ needs
and expectations. This was especially so at the beginning
of rehabilitation, for giving permission about what phys-
ical activity was safe to do. Regular home visits allowed a
relationship to build between patient and rehabilitation
therapist, which was important for patient engagement.
Patients valued the use of tailored care and personal goal
setting as a motivational tool. These activities were well
supported by the workbook and the goal-setting diary.
Strengths and weaknesses
For reasons of patient conﬁdentiality, the cohort used
anonymised data, so it was not possible to match partici-
pants in the cohort with those in the feasibility study.
The numbers suggest that the feasibility study identiﬁed
81% of those in the cohort. It is not known how the
19% who were not identiﬁed in the feasibility study dif-
fered, nor is it known why they were identiﬁed in the
cohort but not in the feasibility study.
This was a single-centre feasibility study conducted in
one local health board at its three acute hospital sites in
North Wales. It was able to assess the feasibility of trial
methods in terms of recruitment, randomisation and
outcome measurement. The NHS REC did not permit
us to recruit participants who lacked mental capacity,
which has implications for the generalisability of our
ﬁndings in this important group. A process evaluation
was performed as part of the feasibility study and will be
reported separately.
We were also able to assess different outcome mea-
sures, to determine which would be the most suitable
for a larger deﬁnitive RCT. As a younger, healthier sub-
population of the cohort was recruited to the feasibility
study, baseline scores for the BADL were high, causing a
ceiling effect in this measure. The NEADL was more
responsive than the BADL for measuring the ability to
perform activities of daily living in this population. The
self-efﬁcacy scales for falls and for exercise were more
responsive than the general self-efﬁcacy scale, but
researchers reported that many participants struggled to
understand the exercise self-efﬁcacy scale, so the falls
self-efﬁcacy scale (FES-I) seems the most appropriate
measure of self-efﬁcacy for the main deﬁnitive RCT. The
most appropriate health economic outcome measure
was EQ-5D. The physical function test with a medium
effect size, ‘50-foot walk’ test, showed better function in
the control than the intervention group. There were
several possible explanations for this anomalous result.
An outlier was identiﬁed which contributed to the
apparent difference and in addition, physical function
tests were performed on average 3 weeks later in the
control group, so participants had longer to recover
from surgery. Because of the nature of the 50-foot walk
test, no adjustment could be made for patients’ function
at baseline. The only physical function test to have this
adjustment was grip strength and here the difference
between the groups at follow-up was reduced by includ-
ing the baseline score as a covariate. It was also only pos-
sible to include results for participants who were able to
complete the test without using any adaptations such as
the use of a walking aid. While the use of cost-utility or
cost-effectiveness analyses have been recommended by
NICE (2011) as needed in the area of proximal femoral
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fracture, they were not appropriate for use in this feasi-
bility study as it was not powered to demonstrate effect-
iveness. However, the cost-consequence analysis used is
championed as a method particularly relevant to eco-
nomic evaluations alongside public health interven-
tions.38–41
While the content of intervention and usual care ses-
sions may have contained similar exercise activities, care
pathways in this area did not use patient-led goal-setting
or provide written information on what to expect during
recovery. In addition, the provision of usual care sessions
was variable, while the intervention offered continuity
and a deﬁnite number of sessions. These were major
components of the intervention, which were only avail-
able to participants randomised to that group. While it
is possible that other participants may have viewed infor-
mation materials if they were used in group sessions, the
one-to-one aspect of the delivery minimised the possibil-
ity of intervention contamination.
Comparison with previous literature
Although there have been other studies of rehabilitation
interventions that combined the promotion of physical
exercise and practice of activities of daily living with psy-
chological interventions designed to tackle self-efﬁcacy
and fear of falling,29 there have been none set in the
UK NHS. While we observed fewer deaths and readmis-
sions in the feasibility study population compared with
our cohort population, the recruitment of younger,
healthier patients to a physical activity or exercise inter-
vention study was not surprising and has been reported
previously.42 The overall recruitment rate of eligible
patients was 23% and the main reason for non-
recruitment was perceived study burden. Challenges in
recruitment into trials, particularly exercise-based
studies, are well documented.43 44 The intervention
applied in this feasibility trial used personalised goal
setting and diaries to provide a record of progress
during rehabilitation, using a similar ethos to two earlier
studies45 46 of patient-centred approaches to rehabilita-
tion. One found that an integrated care pathway with a
focus on motivation for rehabilitation and early ambula-
tion was less costly and more effective than the usual
care pathway.45 The other found that an accelerated
rehabilitation intervention was more cost-effective than
usual care.46 Goal setting and supporting patient’s self-
efﬁcacy was seen to be important in helping patients
engage with their rehabilitation. Another study on
patient empowerment47 also found that empowered
patients were more likely to beneﬁt from their rehabilita-
tion and return to previous living.
Implications for future practice and research
This intervention should be tested in a deﬁnitive phase III
RCT. It would be advantageous to include those who lack
mental capacity as this would improve generalisability of
trial results and increase the pool of potential participants.
Although we were not able to test the feasibility of
recruiting these patients, feedback from healthcare profes-
sionals highlighted the potential beneﬁt of the interven-
tion to those lacking capacity. Owing to the observed
ceiling effect in the BADL in our recruited population,
the primary outcome measure should be the NEADL for
effectiveness and EQ-5D for the economic evaluation. The
FES-I should be used to measure self-efﬁcacy. The adjusted
mean difference in NEADL between groups in this feasi-
bility study was three, which is considered a clinically sig-
niﬁcant change. Others have suggested that the minimum
clinically signiﬁcant difference is 2.4 and so this has been
used within the sample size calculation for a future study.48
Based on a t-test with α of 5% and 90% power to detect a
difference of 2.4 (SD=5.86), 254 participants would be
required to complete the trial over both treatment groups.
When considering the 79% retention rate, a full trial of
similar design would need to recruit 322 participants.
CONCLUSIONS
While recruitment was challenging, we achieved accept-
able recruitment and retention rate. Screening methods
successfully identiﬁed 81% of patients with hip fracture,
but the feasibility study recruited a younger sample with
fewer complications compared with the anonymised
cohort. The intervention was acceptable to patients,
carers and healthcare professionals, and the interven-
tion was viewed positively. The trial methods were feas-
ible, including the collection of costs and outcome data
for a future economic evaluation. Baseline scores in the
intervention and control groups of the feasibility study
were similar, but there was imbalance in the NEADL,
which had a medium effect size while most outcome
measures had a small effect size in favour of the inter-
vention. Owing to the ceiling effect observed in the
BADL and the greater responsiveness of the NEADL,
this should be the primary outcome measure of a future
deﬁnitive RCT.
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